07/03/2025
4:25 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
4:30 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
4:30 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:00 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:00 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2025
3:40 PM | Anavex Life Sciences (Filer)
| Form ARS | |
04/25/2025
3:31 PM | Anavex Life Sciences (Filer)
| Form DEF 14A | |
04/02/2025
8:45 PM | Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
8:45 PM | Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
8:46 PM | Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
8:46 PM | Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
8:47 PM | Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
8:30 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:06 AM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/17/2025
8:12 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
8:14 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
6:00 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
6:00 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:30 PM | Anavex Life Sciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/06/2024
8:00 PM | Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
8:00 PM | Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:21 PM | Anavex Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
4:20 PM | Anavex Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
4:21 PM | Anavex Life Sciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
